|
De Las Heras-Gómez I, Medina S, Casas-Pina T, Marín-Soler L, Tomás A, Martínez-Hernández P, Oger C, Galano JM, Durand T, Jimeno L, Llorente S, Lozoya E, Ferreres F, Gil-Izquierdo Á. Potential applications of lipid peroxidation products - F(4)-neuroprostanes, F(3)-neuroprostanes(n-6 DPA), F(2)-dihomo-isoprostanes and F(2)-isoprostanes - in the evaluation of the allograft function in renal transplantation. Free Radic Biol Med. 2017 Mar;104:178-184. doi: 10.1016/j.freeradbiomed.2017.01.019. Epub 2017 Jan 12. PubMed PMID: 28089724.
AÑO: 2017; IF: 6.02
|
28089724
|
Ruiz J, Ríos A, Rodríguez JM, Llorente S, Jimeno L, Parrilla P. Calcimimetics have had no impact on the indications for surgery of tertiary hyperparathyroidism. Nefrologia. 2017 Nov - Dec;37(6):651-653. doi: 10.1016/j.nefro.2016.10.021. English, Spanish. PubMed PMID: 29122212.
AÑO: 2017; IF: 1.167
|
|
Ruiz J, Ríos A, Rodríguez JM, Llorente S. Spontaneous tendon ruptures in chronic renal failure. Nefrologia. 2017 May - Jun;37(3):341-343. doi: 10.1016/j.nefro.2016.10.018. English, Spanish. PubMed PMID: 28648210.
AÑO: 2017; IF: 1.167
|
|
Ruiz J, Ríos A, Rodríguez JM, Llorente S, Hernández AM, Parrilla P. Impact of calcimimetics in surgery of secondary hyperparathyroidism. Endocrinol Diabetes Nutr. 2017 Jan;64(1):59-61. doi: 10.1016/j.endinu.2016.09.003. Epub 2017 Jan 19. English, Spanish. PubMed PMID: 28440773.
AÑO: 2017
|
|
Boix F, Bolarín JM, Mrowiec A, Eguía J, Gonzalez-Martinez G, de la Peña J, Galian JA, Alfaro R, Moya-Quiles MR, Legaz I, Campillo JA, Ramírez P, García-Alonso A, Pons JA, Sánchez-Bueno F, Minguela A, Llorente S, Muro M. CD28 biomarker quantification and expression level profiles in CD4(+) T-lymphocytes in solid organ transplantation. Transpl Immunol. 2017 Jun;42:9-17. doi: 10.1016/j.trim.2017.04.001. Epub 2017 Apr 6. PubMed PMID: 28392336.
AÑO: 2017; IF: 2.032
|